Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular interactions and functional interference between vitronectin and transforming growth factor-beta.

Michael Schoppet1, Triantafyllos Chavakis, Nadia Al-Fakhri

  • 1Department of Biochemistry, Justus-Liebig-University, Friedrichstrasse 24, D-35392 Giessen, Germany.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|January 18, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular RNA in iron-induced hepatic injury: Beyond TLR3 toward an integrated inflammatory axis.

Toxicology reports·2025
Same author

Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1.

Pharmacological research·2025
Same author

Editor's Note: Cell Surface Tetraspanin Tspan8 Contributes to Molecular Pathways of Exosome-Induced Endothelial Cell Activation.

Cancer research·2025
Same author

Nucleic acid liquid biopsies in cardiovascular disease: Cell-free RNA liquid biopsies in cardiovascular disease.

Atherosclerosis·2024
Same author

The Complement System Is Essential for Arteriogenesis by Enhancing Sterile Inflammation as a Relevant Step in Collateral Artery Growth.

Cells·2024
Same author

Treatment with RNase alleviates brain injury but not neuroinflammation in neonatal hypoxia/ischemia.

Journal of neuroscience research·2024

Vitronectin (VN) binds transforming growth factor-beta (TGF-beta), modulating its functions. This interaction, observed in vitro and in atherosclerotic tissues, suggests VN is a novel TGF-beta binding protein.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Extracellular Matrix Research

Background:

  • Extracellular matrix (ECM) proteins regulate growth factor availability and signaling.
  • Vitronectin (VN), a multifunctional glycoprotein, influences vascular cell functions.
  • VN's interactions with growth factors are hypothesized to mediate its biological activities.

Purpose of the Study:

  • To investigate the interaction between vitronectin (VN) and transforming growth factor-beta (TGF-beta).
  • To determine if VN acts as a binding protein for TGF-beta.
  • To explore the functional consequences of the VN-TGF-beta interaction.

Main Methods:

  • In vitro binding assays using soluble VN and TGF-beta isoforms.
  • Analysis of VN fragments and peptides for TGF-beta binding.

Related Experiment Videos

  • Cell adhesion assays measuring TGF-beta's effect on adhesion to VN.
  • Immunohistochemical analysis of VN and TGF-beta colocalization in atherosclerotic tissues.

    • Main Results:

    • Soluble VN binds TGF-beta1 and TGF-beta2 in a saturable manner.
    • VN's heparin-binding multimeric isoform shows maximal TGF-beta binding.
    • Plasminogen activator inhibitor-1 (PAI-1) interferes with VN-TGF-beta binding, indicating shared binding sites.
    • TGF-beta dose-dependently inhibits cell adhesion to VN, similar to PAI-1's antiadhesive function.
    • VN and TGF-beta colocalize in atherosclerotic tissue sections.

    Conclusions:

    • Vitronectin (VN) is identified as a novel binding protein for TGF-beta.
    • The interaction between VN and TGF-beta modulates the functions of both proteins.
    • VN-TGF-beta interactions may play a role in vascular biology and atherosclerosis.